Xiaoyu Zhang

Mr. Xiaoyu Zhang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
XZXiaoyu Zhang
Xiaoyu Zhang
LZLin Zhu
Lin Zhu
XWXuezhen Wang
Xuezhen Wang
HZHairong Zhang
Hairong Zhang
LWLianzhong Wang
Lianzhong Wang
LXlei xia
lei xia
Curcumin is a polyphenolic substance extracted from plants such as Curcuma longa, Curcuma zedoaria, and radix curcumae, and it has attracted much attention because of the anti-inflammatory, antioxidant, anti-tumor, antibacterial and other multiple pharmacological effects. Cervical cancer is one of the most common malignant tumors in women. With the application of HPV (human papillomavirus) vaccine, the incidence of cervical cancer is expected to be reduced, but it remains difficult to promote the vaccine among low-income population. As a commonly used food additive, curcumin has recently been found to have a significant therapeutic effect in the treatment of cervical cancer. In recent years, numerous in vitro and in vivo studies have found that curcumin can have significant efficacy in anti-cervical cancer treatment by promoting apoptosis, inhibiting tumour cell proliferation, metastasis and invasion, inhibiting HPV and inducing autophagy in tumour cells. However, due to poor water solubility, rapid catabolism, and low bioavailability of curcumin, studies on curcumin derivatives and novel formulations are increasing. Curcumin has a wide range of mechanisms of action against cervical cancer and may become a novel antitumor drug in the future, opening up new ideas for the research of curcumin in the field of antitumor. There is a lack of systematic reviews on the mechanism of action of curcumin against cervical cancer. Therefore, this study is a review of the literature based on the mechanism of action of curcumin against cervical cancer, with a view to providing reference information for scientific and clinical practitioners.

1 March 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
XZXiaoyu Zhang
Xiaoyu Zhang
LZLin Zhu
Lin Zhu
XWXuezhen Wang
Xuezhen Wang
LXlei xia
lei xia
YZYaNan Zhang
YaNan Zhang
Pain is a distressing experience associated with tissue damage or potential tissue damage, and its occurrence is related to sensory, emotional, cognitive and social factors. Inflammatory pain is one of the chronic pains where pain hypersensitivity are functional features of inflammation used to protect tissues from further damage. Pain has a serious impact on people's lives and has become a social problem that cannot be ignored. MiRNAs are small non-coding RNA molecules that exert directing effects on RNA silencing by complementary binding to the 3'UTR of target mRNA. MiRNAs can target a number of protein-coding genes and participate in almost all developmental and pathological processes in animals. Growing studies have suggested that miRNAs have significant implications for inflammatory pain via participating in multiple processes during the occurrence and development, such as affecting the activation of glial cells, regulating pro-inflammatory cytokines and inhibiting central and peripheral sensitization. In this review, the advances in the role of miRNAs in inflammatory pain were discussed. miRNAs as a class of micro-mediators are potential biomarkers and therapeutic targets for inflammatory pain, which provides a better diagnostic and treatment approach for inflammatory pain.

7 September 2024 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
XZXiaoyu Zhang
Xiaoyu Zhang
XWXiaocen Wei
Xiaocen Wei
LSLei Shi
Lei Shi
HJHehe Jiang
Hehe Jiang
FMFengjun Ma
Fengjun Ma
YMYuxia Ma
Yuxia Ma

15 November 2024 in Discover Oncology
Verified
Journal Article
Open access
PDF file
XHXunxing Hao
Xunxing Hao
MDMeng Ding
Meng Ding
CCChenyu Chi
Chenyu Chi
XXXiaodong Xu
Xiaodong Xu
XZXiaoyu Zhang
Xiaoyu Zhang
MHMingzhe Hu
Mingzhe Hu
Digestive system neoplasms are a heterogeneous group of cancers characterized by diverse symptoms, complex diagnosis, and treatment. Prognosis is poor and influenced by multiple factors, making early detection and comprehensive treatment crucial for patient survival. Kaempferol, a flavonoid compound, has attracted attention due to its anti-tumor biological activity, holding promise as a potential drug for treating digestive system neoplasms. Derived from various plants such as cabbage, propolis, and grapefruit, this compound's anti-inflammatory, antioxidant, and other pharmacological effects have been confirmed. Research has found that kaempferol inhibits the occurrence and development of digestive system neoplasms by inducing apoptosis in cancer cells, inhibiting tumor cell proliferation, suppressing tumor metastasis and invasion, and enhancing the effects of other cancer treatment methods. This paper summarizes the role and mechanisms of kaempferol in the study of digestive system neoplasms, providing valuable insights for both scientists and clinical physicians engaged in this field. By detailing the various pathways through which kaempferol exerts its anticancer effects, the paper not only highlights its potential as a therapeutic agent but also opens avenues for further research into its applications.

20 May 2025 in Pharmacological Reports
Verified
Journal Article
Closed access
PDF file
XCXin Chen
Xin Chen
XMXijun Ma
Xijun Ma
XHXiaofei Hu
Xiaofei Hu
CWCihang Wang
Cihang Wang
XZXiaoyu Zhang
Xiaoyu Zhang
CYChunchun Yan
Chunchun Yan

22 May 2025 in Discover Oncology
Verified
Journal Article
Open access
LLLexin Li
Lexin Li
XCXuyang Cui
Xuyang Cui
ZLZhanyu Lin
Zhanyu Lin
YCYiming Chen
Yiming Chen
XZXiaoyu Zhang
Xiaoyu Zhang
YZYong Zhu
Yong Zhu
Colorectal cancer (CRC) remains a malignancy with high incidence and mortality rates worldwide, necessitating the development of more effective therapeutic strategies due to the limitations of current treatments, including drug resistance and adverse effects. Scutellaria baicalensis, a traditional Chinese medicinal herb, contains baicalin and baicalein as its primary bioactive flavonoids, which exhibit notable pharmacological properties such as antibacterial, anti-inflammatory, antioxidant, and antitumor effects. Recent studies have demonstrated that baicalin and baicalein show promising antitumor activity in CRC treatment through mechanisms such as scavenging reactive oxygen species, immune regulation, and inhibition of tumor cell proliferation, induction of apoptosis, and modulation of the gut microenvironment. This study further investigates the molecular mechanisms underlying the therapeutic effects of baicalin and baicalein in CRC, aiming to provide new research perspectives and potential clinical applications for the integration of flavonoid-based compounds from Scutellaria baicalensis in CRC treatment.